Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion
Active, not recruiting · NCT02581137 · Registry updated 2026-06-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Metformin Hydrochloride in Preventing Oral Cancer in Patients With an Oral Premalignant Lesion | Erythroplasia, Head and Neck Neoplasms, Mouth Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Stomatognathic Diseases, erythroplakia, hyperplasia, leukoplakia, mouth disorder, neoplasm, oral cavity carcinoma, oral mucosa leukoplakia, precancerous condition | Active, not recruiting | Phase 2 | 2026-06-26 | NCT02581137 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer Research Centre | Vancouver | Canada | 2 |
| UC San Diego Medical Center - Hillcrest | San Diego | United States | 57 |
| University of British Columbia Hospital | Vancouver | Canada | 3 |
| University of Minnesota/Masonic Cancer Center | Minneapolis | United States | 105 |